TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
暂无分享,去创建一个
J. Massagué | R. Lo | S. Blain | Roger S Lo | Joan Massagué | Stacy W Blain
[1] Andrew V. Nguyen,et al. Transforming growth factor beta3 induces cell death during the first stage of mammary gland involution. , 2000, Development.
[2] S. Choe,et al. Three-finger toxin fold for the extracellular ligand-binding domain of the type II activin receptor serine kinase. , 1999, Nature Structural Biology.
[3] Nobuyuki Shishido,et al. Mice Lacking p27 Kip1 Display Increased Body Size, Multiple Organ Hyperplasia, Retinal Dysplasia, and Pituitary Tumors , 1996, Cell.
[4] S. Mundlos,et al. Cbfa1, a Candidate Gene for Cleidocranial Dysplasia Syndrome, Is Essential for Osteoblast Differentiation and Bone Development , 1997, Cell.
[5] Scott E. Kern,et al. DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1 , 1996, Science.
[6] Chi V. Dang,et al. c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism , 1999, Molecular and Cellular Biology.
[7] Y. Yuasa,et al. Genomic structure of the transforming growth factor beta type II receptor gene and its mutations in hereditary nonpolyposis colorectal cancers. , 1996, Cancer research.
[8] D. Kingsley,et al. Joint patterning defects caused by single and double mutations in members of the bone morphogenetic protein (BMP) family. , 1996, Development.
[9] J. Massagué,et al. Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-β in cells lacking the CDK inhibitor p15 , 1997, Nature.
[10] Georgy Koentges,et al. Neural Crest Apoptosis and the Establishment of Craniofacial Pattern: An Honorable Death , 1996, Molecular and Cellular Neuroscience.
[11] R Wieser,et al. TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. , 1999, The Journal of clinical investigation.
[12] P. Kaldis,et al. Transforming growth factor beta targeted inactivation of cyclin E:cyclin-dependent kinase 2 (Cdk2) complexes by inhibition of Cdk2 activating kinase activity. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[13] H. Ostrer,et al. TβR-I(6A) Is a Candidate Tumor Susceptibility Allele , 1999 .
[14] Irene L Andrulis,et al. MADR2 Maps to 18q21 and Encodes a TGFβ–Regulated MAD–Related Protein That Is Functionally Mutated in Colorectal Carcinoma , 1996, Cell.
[15] Remo Guidieri. Res , 1995, RES: Anthropology and Aesthetics.
[16] J. Picard,et al. Persistence of Müllerian derivatives in males. , 1999, American journal of medical genetics.
[17] Allan Balmain,et al. TGFβ1 Inhibits the Formation of Benign Skin Tumors, but Enhances Progression to Invasive Spindle Carcinomas in Transgenic Mice , 1996, Cell.
[18] J. Massagué,et al. Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. , 1998, Genes & development.
[19] L. Attisano,et al. Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[20] J. Massagué,et al. The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2. , 1997, Genes & development.
[21] F. Luyten,et al. A human chondrodysplasia due to a mutation in a TGF-β superfamily member , 1996, Nature Genetics.
[22] P. Beachy,et al. Genetics of ventral forebrain development and holoprosencephaly. , 2000, Current opinion in genetics & development.
[23] W. Reardon,et al. Mutations in CDMP1 cause autosomal dominant brachydactyly type C , 1997, Nature Genetics.
[24] H. Ostrer,et al. TbetaR-I(6A) is a candidate tumor susceptibility allele. , 1999, Cancer research.
[25] A. Schier,et al. Nodal signalling in vertebrate development , 2000, Nature.
[26] M. Ewen,et al. p53-dependent repression of CDK4 translation in TGF-beta-induced G1 cell-cycle arrest. , 1995, Genes & development.
[27] E. Buscarini,et al. Hereditary haemorrhagic telangiectasia with extensive liver involvement is not caused by either HHT1 or HHT2. , 1996, Journal of medical genetics.
[28] R. W. Padgett,et al. TGF‐β signaling, Smads, and tumor suppressors , 1998 .
[29] L. Wakefield,et al. Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor beta receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7,12-dimethylbenz-[a]-anthracene. , 1997, Cancer research.
[30] H. Lodish,et al. A deletion in the gene for transforming growth factor beta type I receptor abolishes growth regulation by transforming growth factor beta in a cutaneous T-cell lymphoma. , 1999, Blood.
[31] T. Kirsch,et al. Crystal structure of the BMP-2–BRIA ectodomain complex , 2000, Nature Structural Biology.
[32] R. Trembath,et al. Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension , 2000, Nature Genetics.
[33] M. Reiss. Transforming growth factor-beta and cancer: a love-hate relationship? , 1997, Oncology research.
[34] M. Ohue,et al. Microsatellite instability and mutated type II transforming growth factor-beta receptor gene in gliomas. , 1997, Cancer letters.
[35] Liliana Attisano,et al. SARA, a FYVE Domain Protein that Recruits Smad2 to the TGFβ Receptor , 1998, Cell.
[36] H. Moses,et al. Transforming Growth Factor β and Cell Cycle Regulation , 1995 .
[37] M. Owen,et al. Mutations Involving the Transcription Factor CBFA1 Cause Cleidocranial Dysplasia , 1997, Cell.
[38] S. Valgeirsdóttir,et al. Xenopus Smad4beta is the co-Smad component of developmentally regulated transcription factor complexes responsible for induction of early mesodermal genes. , 1999, Developmental biology.
[39] G. Capellá,et al. Disruption of the antiproliferative TGF-β signaling pathways in human pancreatic cancer cells , 1998, Oncogene.
[40] N. Pece-Barbara,et al. Analysis of ALK-1 and endoglin in newborns from families with hereditary hemorrhagic telangiectasia type 2. , 2000, Human molecular genetics.
[41] E. Nishida,et al. Regulation of intracellular dynamics of Smad4 by its leucine‐rich nuclear export signal , 2000, EMBO reports.
[42] Jian-ming Li,et al. Smad3-Smad4 and AP-1 Complexes Synergize in Transcriptional Activation of the c-Jun Promoter by Transforming Growth Factor β , 1999, Molecular and Cellular Biology.
[43] P. Howe,et al. TGF‐β induces fibronectin synthesis through a c‐Jun N‐terminal kinase‐dependent, Smad4‐independent pathway , 1999, The EMBO journal.
[44] Correction: Role of Transforming Growth Factor (beta) in Human Disease. , 2000, The New England journal of medicine.
[45] Takeo Iwama,et al. Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis , 1999, Oncogene.
[46] L. M. Facchini,et al. The molecular role of Myc in growth and transformation: recent discoveries lead to new insights , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[47] K. Miyazono,et al. Interaction and Functional Cooperation of PEBP2/CBF with Smads , 1999, The Journal of Biological Chemistry.
[48] C. Marshall,et al. How do small GTPase signal transduction pathways regulate cell cycle entry? , 1999, Current opinion in cell biology.
[49] D. Dumont,et al. A murine model of hereditary hemorrhagic telangiectasia. , 1999, The Journal of clinical investigation.
[50] M. Reiss,et al. Transforming growth factor beta type I receptor kinase mutant associated with metastatic breast cancer. , 1998, Cancer research.
[51] N. Wake,et al. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer. , 2000, Cancer research.
[52] J. Massagué. TGF-beta signal transduction. , 1998, Annual review of biochemistry.
[53] L. Gold. The role for transforming growth factor-beta (TGF-beta) in human cancer. , 1999, Critical reviews in oncogenesis.
[54] C. Cremers,et al. Heterozygous mutations in the gene encoding noggin affect human joint morphogenesis , 1999, Nature Genetics.
[55] H. Lodish,et al. Role of transforming growth factor beta in human disease. , 2000, The New England journal of medicine.
[56] Kirby D. Johnson,et al. Drosophila Mad binds to DNA and directly mediates activation of vestigial by Decapentaplegic , 1997, Nature.
[57] J. Graff,et al. Smad3 Mutant Mice Develop Metastatic Colorectal Cancer , 1998, Cell.
[58] K. Miyazono,et al. BMP type II receptor is required for gastrulation and early development of mouse embryos. , 2000, Developmental biology.
[59] M. Barcellos-Hoff,et al. Transforming growth factor-β and breast cancer: Mammary gland development , 2000, Breast Cancer Research.
[60] H. Moses,et al. Transforming growth factor beta and cell cycle regulation. , 1995, Cancer research.
[61] H. Poulsen,et al. Transforming growth factor and cancer , 1995 .
[62] James M. Roberts,et al. CDK inhibitors: positive and negative regulators of G1-phase progression. , 1999, Genes & development.
[63] K. Kinzler,et al. Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. , 1995, Cancer research.
[64] S. Kern,et al. Transforming growth factor‐β responsiveness in DPC4/SMAD4‐null cancer cells , 1999 .
[65] J. Westendorf,et al. Mammalian runt‐domain proteins and their roles in hematopoiesis, osteogenesis, and leukemia , 1999, Journal of cellular biochemistry.
[66] Yigong Shi,et al. Crystal Structure of a Smad MH1 Domain Bound to DNA Insights on DNA Binding in TGF-β Signaling , 1998, Cell.
[67] J. Massagué,et al. Controlling TGF-β signaling , 2000, Genes & Development.
[68] R. Hruban,et al. Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas. , 1998, Cancer research.
[69] B. Haye,et al. Involvement of the p38 mitogen‐activated protein kinase pathway in tissue inhibitor of metalloproteinases‐1‐induced erythroid differentiation , 2000, FEBS letters.
[70] K. Lewis,et al. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling , 2000, Nature.
[71] Y. Yatabe,et al. Somatic in vivo alterations of the JV18-1 gene at 18q21 in human lung cancers. , 1996, Cancer research.
[72] A. Iavarone,et al. E2F and Histone Deacetylase Mediate Transforming Growth Factor β Repression of cdc25A during Keratinocyte Cell Cycle Arrest , 1999, Molecular and Cellular Biology.
[73] M. Barbacid,et al. Limited overlapping roles of P15INK4b and P18INK4c cell cycle inhibitors in proliferation and tumorigenesis , 2000, The EMBO journal.
[74] J. Massagué,et al. TGF- SIGNAL TRANSDUCTION , 1998 .
[75] R. Derynck,et al. Transcriptional Activators of TGF-β Responses: Smads , 1998, Cell.
[76] L. Baudhuin,et al. Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1 , 2000, Nature Cell Biology.
[77] S. Hodge,et al. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. , 2000, American journal of human genetics.
[78] W. Wooster,et al. Crystal structure of , 2005 .
[79] Keunchil Park,et al. Expression of Transforming Growth Factor β Type II Receptor Reduces Tumorigenicity in Human Gastric Cancer Cells , 1997 .
[80] E. Nishida,et al. Identification of Two Smad4 Proteins in Xenopus , 1999, The Journal of Biological Chemistry.
[81] A. Guttmacher,et al. Hereditary hemorrhagic telangiectasia. , 1995, The New England journal of medicine.
[82] E. Zackai,et al. Mutations in TGIF cause holoprosencephaly and link NODAL signalling to human neural axis determination , 2000, Nature Genetics.
[83] M. Goumans,et al. Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice. , 2000, The International journal of developmental biology.
[84] A. McMahon,et al. Noggin-mediated antagonism of BMP signaling is required for growth and patterning of the neural tube and somite. , 1998, Genes & development.
[85] S. Kern,et al. Transforming growth factor-beta responsiveness in DPC4/SMAD4-null cancer cells. , 1999, Molecular carcinogenesis.
[86] J. Yokota,et al. Mutation analysis of coding sequences of the entire transforming growth factor beta type II receptor gene in sporadic human colon cancer using genomic DNA and Intron primers , 1997, Oncogene.
[87] D. Beach,et al. Cdc25 cell-cycle phosphatase as a target of c-myc , 1996, Nature.
[88] Xiao‐Jing Wang,et al. Aberrant cell cycle progression contributes to the early-stage accelerated carcinogenesis in transgenic epidermis expressing the dominant negative TGFβRII , 2000, Oncogene.
[89] J. Massagué,et al. Transcriptional control by the TGF‐β/Smad signaling system , 2000 .
[90] J. Massagué,et al. Smad1 Recognition and Activation by the ALK1 Group of Transforming Growth Factor-β Family Receptors* , 1999, The Journal of Biological Chemistry.
[91] D. Marchuk,et al. Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. , 2000, Developmental biology.
[92] Yigong Shi,et al. A structural basis for mutational inactivation of the tumour suppressor Smad4 , 1997, Nature.
[93] K. Kinzler,et al. Human Smad3 and Smad4 are sequence-specific transcription activators. , 1998, Molecular cell.
[94] Makoto Sato,et al. Targeted Disruption of Cbfa1 Results in a Complete Lack of Bone Formation owing to Maturational Arrest of Osteoblasts , 1997, Cell.
[95] D. Kingsley,et al. GDF5 coordinates bone and joint formation during digit development. , 1999, Developmental biology.
[96] L. Attisano,et al. Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[97] F. Luyten,et al. Mechanisms of GDF-5 action during skeletal development. , 1999, Development.
[98] R. Sutherland,et al. Mechanisms of Cyclin-Dependent Kinase Inactivation by Progestins , 1998, Molecular and Cellular Biology.
[99] G. Hannon,et al. p53-Independent Role of MDM2 in TGF-β1 Resistance , 1998 .
[100] Kathleen R. Cho,et al. A transforming growth factor beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. , 1995, Cancer research.
[101] P. Hoodless,et al. Specific Activation of Smad1 Signaling Pathways by the BMP7 Type I Receptor, ALK2* , 1998, The Journal of Biological Chemistry.
[102] Kohei Miyazono,et al. TGF-β signalling from cell membrane to nucleus through SMAD proteins , 1997, Nature.
[103] A. McMahon,et al. Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. , 1998, Science.
[104] S. Germain,et al. Homeodomain and winged-helix transcription factors recruit activated Smads to distinct promoter elements via a common Smad interaction motif. , 2000, Genes & development.
[105] J. Massagué,et al. The nuclear import function of Smad2 is masked by SARA and unmasked by TGFb-dependent phosphorylation , 2000, Nature Cell Biology.
[106] Frank P. Luyten,et al. Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1 , 1997, Nature Genetics.
[107] S. R. Hann,et al. A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta -induced cell-cycle arrest. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[108] T. Kirsch,et al. BMP‐2 antagonists emerge from alterations in the low‐affinity binding epitope for receptor BMPR‐II , 2000, The EMBO journal.
[109] H. Moses,et al. Interdependent SMAD and JNK Signaling in Transforming Growth Factor-β-mediated Transcription* , 1999, The Journal of Biological Chemistry.
[110] J. Massagué,et al. A Smad Transcriptional Corepressor , 1999, Cell.
[111] R. W. Padgett,et al. TGF-beta signaling, Smads, and tumor suppressors. , 1998, BioEssays : news and reviews in molecular, cellular and developmental biology.
[112] R. Weinberg,et al. Transforming growth factor beta effects on expression of G1 cyclins and cyclin-dependent protein kinases. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[113] T. Iwama,et al. Transforming growth factor beta type II receptor gene mutations in adenomas from hereditary nonpolyposis colorectal cancer. , 1997, Gastroenterology.
[114] J. Massagué,et al. Controlling TGF-beta signaling. , 2000, Genes & development.
[115] A. Saltzman,et al. Transforming Growth Factor-β-Mediated Apoptosis in the Ramos B-Lymphoma Cell Line Is Accompanied by Caspase Activation and Bcl-XLDownregulation , 1998 .
[116] C. Arteaga,et al. Transforming Growth Factor-β and Breast Cancer , 1999 .
[117] J. Massagué,et al. Betaglycan presents ligand to the TGFβ signaling receptor , 1993, Cell.
[118] J. Massagué,et al. Myc Downregulation by Transforming Growth Factor β Required for Activation of the p15Ink4b G1 Arrest Pathway , 1999, Molecular and Cellular Biology.
[119] A. Iavarone,et al. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. , 1995, Genes & development.
[120] Gregory J. Hannon,et al. pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest , 1994, Nature.
[121] N. Pavletich. Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors. , 1999, Journal of molecular biology.
[122] D. Marchuk,et al. Expression analysis of endoglin missense and truncation mutations: insights into protein structure and disease mechanisms. , 2000, Human molecular genetics.
[123] R. Weinberg,et al. SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor beta signaling. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[124] K. Kinzler,et al. Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers. , 1999, Cancer research.
[125] S. Tashiro,et al. ATF-2 Is a Common Nuclear Target of Smad and TAK1 Pathways in Transforming Growth Factor-β Signaling* , 1999, The Journal of Biological Chemistry.
[126] Naoto Ueno,et al. Interaction between Wnt and TGF-β signalling pathways during formation of Spemann's organizer , 2000, Nature.
[127] R. Derynck,et al. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription , 1998, Nature.
[128] Y G Chen,et al. Engagement of bone morphogenetic protein type IB receptor and Smad1 signaling by anti-Müllerian hormone and its type II receptor. , 2000, The Journal of biological chemistry.
[129] H. Beug,et al. TGFβ signaling is necessary for carcinoma cell invasiveness and metastasis , 1998, Current Biology.
[130] A. Baldini,et al. Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia , 1997, Nature Genetics.
[131] Smads and early developmental signaling by the TGFbeta superfamily. , 1998, Genes & development.
[132] M. Gimbrone,et al. A role for Smad6 in development and homeostasis of the cardiovascular system , 2000, Nature Genetics.
[133] L. Pradayrol. TGF-b : signal transduction pathways and tumor suppressor genes , 2000 .
[134] J. Massagué,et al. Determinants of specificity in TGF-beta signal transduction. , 1998, Genes & development.
[135] R. H. Chen,et al. Involvement of caspase family proteases in transforming growth factor-beta-induced apoptosis. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[136] A. Kulkarni,et al. Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. , 1995, Development.
[137] P. Hoodless,et al. Formation of the definitive endoderm is a Smad2-dependent process , 2000 .
[138] P. Yaswen,et al. Transforming growth factor beta stabilizes p15INK4B protein, increases p15INK4B-cdk4 complexes, and inhibits cyclin D1-cdk4 association in human mammary epithelial cells , 1997, Molecular and cellular biology.
[139] L. Aaltonen,et al. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. , 1998, Science.
[140] D. Marchuk,et al. Expression analysis of four endoglin missense mutations suggests that haploinsufficiency is the predominant mechanism for hereditary hemorrhagic telangiectasia type 1. , 1999, Human molecular genetics.
[141] E. Gabrielson,et al. The S387Y mutations of the transforming growth factor-beta receptor type I gene is uncommon in metastases of breast cancer and other common types of adenocarcinoma. , 1999, Cancer research.
[142] K. Kinzler,et al. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. , 1995, Science.
[143] R. Behringer,et al. High Specificity of Müllerian-Inhibiting Substance Signaling in Vivo. , 1999, Endocrinology.
[144] M. Orgebin-Crist,et al. Molecular mechanisms of hormone-mediated Müllerian duct regression: involvement of beta-catenin. , 2000, Development.
[145] J. Massagué,et al. A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras. , 1999, Genes & development.
[146] Hiroyuki Miyoshi,et al. Intestinal Tumorigenesis in Compound Mutant Mice of both Dpc4(Smad4) and Apc Genes , 1998, Cell.
[147] J. Massagué,et al. BMP signaling and vertebrate limb development. , 1997, Cold Spring Harbor symposia on quantitative biology.
[148] N. Copeland,et al. Limb alterations in brachypodism mice due to mutations in a new member of the TGFβ-superfamily , 1994, Nature.
[149] T. Mitsudomi,et al. Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers. , 1996, Cancer research.
[150] L. Wakefield,et al. Transgenic Mice Overexpressing a Dominant-negative Mutant Type II Transforming Growth Factor β Receptor Show Enhanced Tumorigenesis in the Mammary Gland and Lung in Response to the Carcinogen 7,12-Dimethylbenz-[a]-anthracene , 1997 .
[151] L. Wakefield,et al. Transforming growth factor-β1 is a new form of tumor suppressor with true haploid insufficiency , 1998, Nature Medicine.
[152] H. Taussig,et al. Primary pulmonary hypertension. , 1952, A.M.A. American journal of diseases of children.
[153] Morgan Huse,et al. Crystal Structure of the Cytoplasmic Domain of the Type I TGF β Receptor in Complex with FKBP12 , 1999, Cell.
[154] L. Raftery,et al. TGF-beta family signal transduction in Drosophila development: from Mad to Smads. , 1999, Developmental biology.
[155] Qiang Zhou,et al. The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling. , 1999, Genes & development.
[156] Luzhe Sun,et al. Demonstration That Mutation of the Type II Transforming Growth Factor β Receptor Inactivates Its Tumor Suppressor Activity in Replication Error-positive Colon Carcinoma Cells (*) , 1995, The Journal of Biological Chemistry.
[157] M. O’Connor,et al. TAK1 Participates in c-Jun N-Terminal Kinase Signaling during Drosophila Development , 2000, Molecular and Cellular Biology.
[158] P. Hoodless,et al. Targeted Disruption in Murine Cells Reveals Variable Requirement for Smad4 in Transforming Growth Factor β-related Signaling* , 2000, The Journal of Biological Chemistry.
[159] T. Grundström,et al. Smad and AML Proteins Synergistically Confer Transforming Growth Factor β1 Responsiveness to Human Germ-line IgA Genes* , 2000, The Journal of Biological Chemistry.
[160] S. Mundlos. Cleidocranial dysplasia: clinical and molecular genetics , 1999, Journal of medical genetics.
[161] B. Hogan,et al. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. , 1996, Genes & development.
[162] P. Donahoe,et al. Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[163] Lin Chen,et al. Haploid loss of the tumor suppressor Smad4/Dpc4 initiates gastric polyposis and cancer in mice , 2000, Oncogene.